Adlai Nortye Ltd. American Depositary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ANL Company Description
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
ANL Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ANL Smart Score
Score Breakdown
ANL Company Description
Show More
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ANL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ANL's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on ANL's company Twitter account
WallStreetBets
Number of mentions of ANL in WallStreetBets Daily Discussion
ANL News
Recent insights relating to ANL
CNBC Recommendations
Recent picks made for ANL stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ANL
Corporate Flights
Flights by private jets registered to ANL
Our Analysis